Published in J Trauma on June 01, 1991
Aloe vera gel and thyroid hormone cream may improve wound healing in Wistar rats. Anat Cell Biol (2012) 0.89
The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma (1993) 0.78
A comparative study of the effects of topical application of Aloe vera, thyroid hormone and silver sulfadiazine on skin wounds in Wistar rats. Lab Anim Res (2012) 0.78
Photodynamic inactivation of fibroblasts by a cationic porphyrin. Lasers Med Sci (2005) 0.77
Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns. Int J Pharm Investig (2016) 0.75
The Bactericidal And Cytotoxic Effects Of Antimicrobial Wound Cleansers. J Athl Train (2002) 0.75
Surface Defection Reduces Cytotoxicity of Zn(2-methylimidazole)2 (ZIF-8) without Compromising its Drug Delivery Capacity. RSC Adv (2015) 0.75
In Vitro activity of Manuka Honey and polyhexamethylene biguanide on filamentous fungi and toxicity to human cell lines. Med Mycol (2017) 0.75
The effect of phenytoin cream in comparison with betadine solution on episiotomy pain of primiparous women. J Caring Sci (2012) 0.75
Cardiopulmonary resuscitation by medical and surgical house-officers. Lancet (1981) 6.33
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immunol (1989) 3.43
Video recording trauma resuscitations: an effective teaching technique. J Trauma (1988) 2.44
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Prospective, randomized trial of hypertonic sodium lactate versus lactated Ringer's solution for burn shock resuscitation. J Trauma (1989) 1.47
CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci U S A (1994) 1.40
Influence of head and neck position on endotracheal tube tip position on chest x-ray examination: a potential problem in the infant undergoing intubation. J Burn Care Rehabil (1995) 1.39
Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev (1997) 1.39
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition. Arch Surg (1994) 1.38
Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res (2000) 1.37
Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma (1987) 1.11
Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery (1988) 1.08
Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res (1988) 1.08
Comparison of Biobrane and Scarlet Red dressings for treatment of donor site wounds. Arch Surg (1985) 1.02
Use of overhead hooks in burn surgery. J Burn Care Rehabil (1989) 1.01
Reduction of bacterial translocation and intestinal structural alterations by heparin in a murine burn injury model. J Trauma (1994) 0.98
Placement of 10-gauge catheter by cutdown for rapid fluid replacement. J Trauma (1983) 0.97
Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am J Surg (1984) 0.95
Immunosuppression by hyperbaric oxygen. Surgery (1980) 0.95
A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil (1997) 0.94
Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch Dermatol Res (1997) 0.93
Postburn immunosuppression in an animal model: monocyte dysfunction induced by burned tissue. Surgery (1983) 0.93
Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors. Surgery (1991) 0.92
In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials (1991) 0.92
Current concepts in the development of cultured skin replacements. J Surg Res (1996) 0.91
Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res (1990) 0.91
Clinical experience with Biobrane biosynthetic dressing in the treatment of partial thickness burns. Burns Incl Therm Inj (1984) 0.90
Reconstitution of the histologic characteristics of a giant congenital nevomelanocytic nevus employing the athymic mouse and a cultured skin substitute. J Invest Dermatol (1991) 0.90
Safety and efficacy of TransCyte for the treatment of partial-thickness burns. J Burn Care Rehabil (1999) 0.89
Warfarin-induced skin necrosis: an entity occasionally requiring burn wound expertise. Burns Incl Therm Inj (1988) 0.89
Microbial contamination in allografted wound beds in patients with burns. J Burn Care Rehabil (1992) 0.88
Postburn immunosuppression in an animal model. III. Maintenance of normal splenic helper and suppressor lymphocyte subpopulations by immunomodulating drugs. Surgery (1985) 0.88
Management of cutaneous manifestations of extensive purpura fulminans in a burn unit. J Burn Care Rehabil (1992) 0.87
Thermoregulation in burn patients during exercise. J Burn Care Rehabil (2003) 0.87
Effect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions. Crit Care Med (1990) 0.86
Bacterial translocation in burned mice after administration of various diets including fiber- and glutamine-enriched enteral formulas. Crit Care Med (1994) 0.86
Postburn serum drug binding and serum protein concentrations. J Clin Pharmacol (1986) 0.86
Frequencies of T cells secreting IL-2 and/or IL-4 among unprimed CD4+ populations. Evidence that clones secreting IL-2 and IL-4 give rise to clones which secrete only IL-4. Immunol Lett (1990) 0.86
Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med (1992) 0.86
Postburn immunosuppression in an animal model. IV. Improved resistance to septic challenge with immunomodulating drugs. Surgery (1986) 0.85
Success of immediate intragastric feeding of patients with burns. J Burn Care Rehabil (1993) 0.85
Head injury: an immunologic deficit in T-cell activation. J Trauma (1990) 0.84
Immunomodulation following burn injury. Surg Clin North Am (1987) 0.84
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. J Neuroimmunol (1997) 0.84
CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes. Ann N Y Acad Sci (1995) 0.83
Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn wounds. J Trauma (1999) 0.83
Immunomodulating drugs increase resistance against sepsis in traumatized mice. J Trauma (1986) 0.83
Antibody formation after murine injury. J Surg Res (1988) 0.83
Enteral nutritional support and wound excision and closure do not prevent postburn hypermetabolism as measured by continuous metabolic monitoring. J Trauma (2000) 0.83
Granulocyte stem cells are decreased in humans with fatal burns. J Trauma (1985) 0.82
Development of a device for measuring adherence of skin grafts to the wound surface. Ann Biomed Eng (1993) 0.82
Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg (1986) 0.82
Spontaneous bacterial peritonitis and pneumoperitoneum. A false surgical emergency. JAMA (1983) 0.82
Management of skin-grafted burn wounds with Xeroform and layers of dry coarse-mesh gauze dressing results in excellent graft take and minimal nursing time. J Burn Care Rehabil (1996) 0.81
Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients. Am J Surg (1984) 0.81
Direct comparison of a cultured composite skin substitute containing human keratinocytes and fibroblasts to an epidermal sheet graft containing human keratinocytes on athymic mice. J Invest Dermatol (1993) 0.81
Hypersensitivity to Biobrane. Plast Reconstr Surg (1986) 0.81
Current trends in the use of allograft skin for patients with burns and reflections on the future of skin banking in the United States. J Burn Care Rehabil (1995) 0.81
Cyclosporine A for prolonging allograft survival in patients with massive burns. J Burn Care Rehabil (1991) 0.81
A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients. J Burn Care Rehabil (2001) 0.80
Acellular human dermis promotes cultured keratinocyte engraftment. J Burn Care Rehabil (1998) 0.80
Ultrastructural features of composite skin cultures grafted onto athymic mice. J Anat (1994) 0.80
Use of a composite skin graft composed of cultured human keratinocytes and fibroblasts and a collagen-GAG matrix to cover full-thickness wounds on athymic mice. Surgery (1991) 0.80
Biotinylation of implantable collagen for drug delivery. J Biomed Mater Res (1992) 0.80
Arteriovenous fistulas following central venous catheterization. Intensive Care Med (1983) 0.80
Immunosuppression with hyperbaric oxygen. Surg Forum (1979) 0.80
Insulin-secretory-granule specific T cell clones in human IDDM. J Autoimmun (1995) 0.80
Wound closure with human keratinocytes cultured on a polyurethane dressing overlaid on a cultured human dermal replacement. Surgery (1996) 0.79
Quantitation of cytokine levels in skin graft donor site wound fluid. Burns (1993) 0.79
Supplementation of an elemental enteral diet with alanyl-glutamine decreases bacterial translocation in burned mice. Burns (1994) 0.79
Attachment of peptide growth factors to implantable collagen. J Surg Res (1989) 0.79
Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care. J Burn Care Rehabil (1993) 0.79
Absence of tumorigenicity in athymic mice by normal human epidermal keratinocytes after culture in serum-free medium. Cancer Lett (1992) 0.79
The effects of epidermal growth factor and basic fibroblast growth factor on epithelialization of meshed skin graft interstices. Prog Clin Biol Res (1991) 0.79
Prevention of posttraumatic alterations in lymphocyte subpopulations in mice by immunomodulating drugs. Arch Surg (1986) 0.78
Pharmacokinetics of DepoFoam gentamicin delivery system and effect on soft tissue infection. J Surg Res (1993) 0.78
Burn injury results in decreased gastric acid production in the acute shock period. J Burn Care Rehabil (1996) 0.78
Cardiovascular and neurohumoral responses following burn injury. Arch Surg (1990) 0.78
Soft tissue infection prophylaxis with gentamicin encapsulated in multivesicular liposomes: results from a prospective, randomized trial. Crit Care Med (1995) 0.78
Trauma peptide induction of lymphocyte changes predictive of sepsis. J Surg Res (1988) 0.78
Temporal analysis of human leucocyte surface antigen expression and neutrophil respiratory burst activity after thermal injury. Burns (1993) 0.77
Hydrocarbon contact injuries. J Trauma (1985) 0.77
Cardiac perforation and tamponade from a malpositioned subclavian dialysis catheter. Nephron (1982) 0.77
Effects of early and delayed wound excision on pulmonary leukosequestration and neutrophil respiratory burst activity in burned mice. Surgery (1995) 0.77
Reduced wound contraction after grafting of full-thickness burns with a collagen and chondroitin-6-sulfate (GAG) dermal skin substitute and coverage with biobrane. J Burn Care Rehabil (1989) 0.77
Characterization of the immunosuppressive effect of burned tissue in an animal model. J Surg Res (1984) 0.77
Restoration of immunity in burned mice by cimetidine. J Trauma (1985) 0.77
Defective T-cell surface antigen expression after mitogen stimulation. An index of lymphocyte dysfunction after controlled murine injury. Ann Surg (1989) 0.76
Alterations in splenic lymphocyte subpopulations and increased mortality from sepsis following anesthesia in mice. Anesthesiology (1985) 0.76
The effect of an arginine-glycine-aspartic acid peptide and hyaluronate synthetic matrix on epithelialization of meshed skin graft interstices. J Burn Care Rehabil (1996) 0.76
Patient tolerance study of topical chlorhexidine diphosphanilate: a new topical agent for burns. Burns (1990) 0.76
Identification and antibiotic susceptibility of bacterial isolates from burned patients. Burns Incl Therm Inj (1985) 0.76
Modulation of suppressor cell activity and improved resistance to infection in the burned mouse. J Burn Care Rehabil (1987) 0.76